Abiopharma

News list

Quinlan Paul T 🔴 sold 733 shares of Oruka Therapeutics, Inc. (ORKA) at $69.69 Transaction Date: Jun 15, 2026 | Filing ID: 000060

Full text

News bot June 15, 2026, 10:50 p.m.
🔍 Quinlan Paul T (Executive)

Company: Oruka Therapeutics, Inc. (ORKA)

Report Date: 2026-06-15
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 733
Detailed Transactions and Holdings:
- Sold 733 shares of Common Stock at $69.69 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,034.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units.